Arginine Treatment of Acute Chest Syndrome (Pneumonia) in Sickle Cell Disease Patients
NCT00029731 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2015-03-25
Summary
This is a study to determine if oral arginine will increase nitric oxide in sickle cell disease (SCD) patients with acute chest syndrome (ACS). It will also assess the effects of arginine in the body and how the body uses nitric oxide in ACS.
Conditions
- Anemia, Sickle Cell
- Pneumonia
Interventions
- DRUG
-
Arginine hydrochloride
Sponsors & Collaborators
-
UCSF Benioff Children's Hospital Oakland
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Model
- PARALLEL
Eligibility
- Min Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-08-31
- Completion
- 2005-07-31
Countries
- United States
Study Locations
More Related Trials
-
Role of Placenta Growth Factor in Sickle Acute Chest Syndrome
NCT00448370 ·Status: COMPLETED
-
Nitric Oxide Inhalation to Treat Sickle Cell Pain Crises
NCT00094887 ·Status: COMPLETED ·Phase: PHASE2
-
Inhaled Nitric Oxide for Pediatric Painful Sickle Crisis
NCT00142051 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase 1 Study of Continuous Intravenous L-citrulline During Sickle Cell Pain Crisis or Acute Chest Syndrome
NCT02697240 ·Status: COMPLETED ·Phase: PHASE1
-
Early Diagnosis of Sickle Acute Chest Syndrome Using a Combination of Plasma Bimarkers and Chest Imaging
NCT03478917 ·Status: COMPLETED
-
Evaluation of Hydroxyurea Plus L-arginine or Sildenafil to Treat Sickle Cell Anemia
NCT00056433 ·Status: COMPLETED ·Phase: PHASE1
-
Defibrotide in Sickle Cell Disease-Related Acute Chest Syndrome
NCT03805581 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Nitric Oxide and Nitroglycerin in Patients With Sickle Cell Anemia
NCT00001716 ·Status: COMPLETED ·Phase: PHASE2
-
Preventing Acute Chest Syndrome by Transfusion Feasibility Study
NCT00951808 ·Status: COMPLETED ·Phase: NA
-
Nitric Oxide to Improve Blood Flow in Sickle Cell Disease
NCT00009581 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Oral L-citrulline in Sickle Cell Disease
NCT02659644 ·Status: WITHDRAWN ·Phase: PHASE1
-
TRF-1101 Assessment in Sickle Cell Disease
NCT00773890 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Sickle Cell Disease Treatment With Arginine Therapy (STArT) Trial
NCT04839354 ·Status: COMPLETED ·Phase: PHASE3
-
PK and PD Responses to Oral L-Citrulline in Patients With Sickle Cell Disease
NCT00343954 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Evaluate Safety, Pharmacokinetic, and Biological Activity of INCB059872 in Subjects With Sickle Cell Disease
NCT03132324 ·Status: TERMINATED ·Phase: PHASE1
-
Use of Macrolides in Acute Chest Syndrome: A Multicenter Retrospective Study
NCT07037706 ·Status: COMPLETED
-
Intranasal Fentanyl for Initial Treatment of a Vaso-occlusive Crisis
NCT01482091 ·Status: COMPLETED ·Phase: PHASE4
-
Quantifying the Presence of Lung Disease and Pulmonary Hypertension in Children With Sickle Cell Disease
NCT01895998 ·Status: COMPLETED ·Phase: PHASE1
-
Phase II Randomized Trial:Arginine Butyrate Plus Standard Local Therapy in Patients With Refractory Sickle Cell Ulcers
NCT00004412 ·Status: COMPLETED ·Phase: PHASE2
-
To Assess Safety, Tolerability and Physiological Effects on Structure and Function of AXA4010 in Subjects With Sickle Cell Disease
NCT04134299 ·Status: COMPLETED ·Phase: NA
-
Nitric Oxide Therapy for Acute Chest Syndrome in Sickle Cell Disease Children
NCT01089439 ·Status: COMPLETED ·Phase: PHASE2
-
Cardiovascular Complications of Sickle Cell Disease
NCT01044901 ·Status: COMPLETED
-
N-Acetylcysteine in Patients With Sickle Cell Disease
NCT01849016 ·Status: COMPLETED ·Phase: PHASE3
-
Dose-Escalation Study of SCD-101 in Sickle Cell Disease
NCT02380079 ·Status: UNKNOWN ·Phase: PHASE1
-
Therapeutic Anticoagulation Strategy for Acute Chest Syndrome
NCT02580773 ·Status: COMPLETED ·Phase: PHASE3